GOLDMAN SACHS GROUP INC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 886982 NEW YORK, NY

Position in ACHV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$449,678

-$1,791,434 QoQ

Shares Held

152,952

-66.1% QoQ

Ownership

0.149%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#22

of 81 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. ACHV ranks #292 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc.	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$449,678	152,952	-66.1%	Shares	Defined	2026-05-15
2025-12-31	$2,241,112	450,928	+101.5%	Shares	Defined	2026-03-25
2025-09-30	$705,073	223,833	+273.6%	Shares	Defined	2025-11-14
2025-06-30	$135,407	59,915	-45.7%	Shares	Defined	2025-08-14
2025-03-31	$294,623	110,346	-27.0%	Shares	Defined	2025-06-27
2024-12-31	$532,136	151,175	-35.6%	Shares	Defined	2025-02-11
2024-09-30	$1,113,260	234,865	+580.0%	Shares	Defined	2024-11-14
2024-06-30	$162,328	34,538	+55.5%	Shares	Defined	2024-08-13
2024-03-31	$101,091	22,218	+105.4%	Shares	Defined	2024-05-15
2020-12-31	$87,609	10,816	—	Shares	Defined	2021-02-12
No filing history on record for this holder in this stock.